Benzoyl-beta-alanine; 3-benzamidopropanoic acid; N-Benzoyl-beta-alanine; 3-Benzamidopropionic acid; Betamipron [INN:JAN]; N-(phenylcarbonyl)-beta-alanine; 3-(Benzoylamino)propionic acid; beta-Alanine, N-benzoyl-; UNII-3W0M245736; MLS000069643; CHEMBL1231530; 3-(phenylformamido)propanoic acid; NCGC00018241-04; SMR000058183; 3W0M245736; DSSTox_CID_25626; DSSTox_RID_81011; DSSTox_GSID_45626; Betamipronum; Betamipronum [INN-Latin]; BRN 2212769; Betamipron, INN; Benzoyl-b-alanine; CS-443; Spectrum_001630; Benzoyl-.beta.-alanine; Betamipron (JAN/INN); Opera_ID_1673; Spectrum2_000434; Spectrum3_001214; Spectrum4_000635; Spectrum5_001432; N-Benzoyl-.beta.-alanine; N-Benzoyl-beta-alanine #; Benzoyl-dl-.beta.-alanine; Betamipron (JP17/INN); 3-benzoylaminopropionic acid; Cambridge id 5117019; N-Benzoyl-b-alanine, 9CI; Oprea1_327957; BSPBio_002628; CBDivE_001204; KBioGR_001250; KBioSS_002110; 3-Benzoylamino-propionic acid; 4-09-00-00796 (Beilstein Handbook Reference); SCHEMBL605899; SPECTRUM1504244; SPBio_000448; ACMC-209i77; DTXSID0045626; SCHEMBL20548456; KBio2_002110; KBio2_004678; KBio2_007246; KBio3_002128; ZINC12614; HMS1577C12; HMS1922H19; HMS2235A09; HMS3370D05; HMS3652F09; Pharmakon1600-01504244; ALBB-010043; HY-B1127; KS-00000XN3; Tox21_110845; 3-(phenylcarbonylamino)propanoic acid; ANW-27857; BBL000483; BDBM50344964; CCG-39973; MFCD00037293; NSC192714; NSC758708; s4191; STK288042; AKOS000263883; Tox21_110845_1; CS-4674; MCULE-7715802662; NSC-192714; NSC-758708; NCGC00018241-01; NCGC00018241-02; NCGC00018241-03; NCGC00018241-05; NCGC00018241-07; NCGC00021511-03; NCGC00021511-04; AS-13812; SBI-0207055.P001; AB0017058; DB-014712; B0099; FT-0679640; ST45137219; SW100974-2; A14818; D01331; J10360; Y-9240; AB00384351_13; AB00384351_14; SR-01000000193; Q4897351; SR-01000000193-2; BRD-K82142815-001-02-7; BRD-K82142815-001-12-6; Z56854345